FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse March 29, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse